These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 18056737

  • 1. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
    Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N.
    Brain; 2008 Jan; 131(Pt 1):288-303. PubMed ID: 18056737
    [Abstract] [Full Text] [Related]

  • 2. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult.
    Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N.
    Brain Pathol; 2003 Oct; 13(4):554-73. PubMed ID: 14655760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation.
    Cannella B, Raine CS.
    Ann Neurol; 2004 Jan; 55(1):46-57. PubMed ID: 14705111
    [Abstract] [Full Text] [Related]

  • 5. Cytokines, chemokines, and cytokine receptors in human microglia.
    Lee YB, Nagai A, Kim SU.
    J Neurosci Res; 2002 Jul 01; 69(1):94-103. PubMed ID: 12111820
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.
    Vercellino M, Trebini C, Capello E, Mancardi GL, Giordana MT, Cavalla P.
    J Neuroimmunol; 2017 Nov 15; 312():49-58. PubMed ID: 28919237
    [Abstract] [Full Text] [Related]

  • 11. The effects of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium.
    Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K.
    Invest Ophthalmol Vis Sci; 2003 Feb 15; 44(2):514-20. PubMed ID: 12556377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
    Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D.
    J Neuroimmunol; 2004 Jul 15; 152(1-2):154-67. PubMed ID: 15223248
    [Abstract] [Full Text] [Related]

  • 17. Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
    Jäckle K, Zeis T, Schaeren-Wiemers N, Junker A, van der Meer F, Kramann N, Stadelmann C, Brück W.
    Brain; 2020 Jul 01; 143(7):2073-2088. PubMed ID: 32577755
    [Abstract] [Full Text] [Related]

  • 18. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
    Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D.
    Brain; 2001 Sep 01; 124(Pt 9):1743-53. PubMed ID: 11522577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.